9-133352086-C-T
Variant summary
Our verdict is Likely pathogenic. The variant received 9 ACMG points: 9P and 0B. PM1PM2PP2PP3_Strong
The NM_003172.4(SURF1):c.808G>A(p.Glu270Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000186 in 1,610,816 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. E270E) has been classified as Likely benign.
Frequency
Consequence
NM_003172.4 missense
Scores
Clinical Significance
Conservation
Publications
- Leigh syndromeInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
- mitochondrial complex IV deficiency, nuclear type 1Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
- Charcot-Marie-Tooth disease type 4KInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- Leigh syndrome with cardiomyopathyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Leigh syndrome with leukodystrophyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 9 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_003172.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SURF1 | NM_003172.4 | MANE Select | c.808G>A | p.Glu270Lys | missense | Exon 8 of 9 | NP_003163.1 | ||
| SURF1 | NM_001280787.1 | c.481G>A | p.Glu161Lys | missense | Exon 7 of 8 | NP_001267716.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SURF1 | ENST00000371974.8 | TSL:1 MANE Select | c.808G>A | p.Glu270Lys | missense | Exon 8 of 9 | ENSP00000361042.3 | ||
| SURF1 | ENST00000615505.4 | TSL:1 | c.481G>A | p.Glu161Lys | missense | Exon 7 of 8 | ENSP00000482067.1 | ||
| SURF1 | ENST00000437995.1 | TSL:5 | n.718G>A | non_coding_transcript_exon | Exon 7 of 8 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152180Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000245 AC: 6AN: 244630 AF XY: 0.0000302 show subpopulations
GnomAD4 exome AF: 0.0000192 AC: 28AN: 1458636Hom.: 0 Cov.: 33 AF XY: 0.0000221 AC XY: 16AN XY: 725258 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152180Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74344 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
ClinVar
Submissions by phenotype
Leigh syndrome Uncertain:1
This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 270 of the SURF1 protein (p.Glu270Lys). This variant is present in population databases (rs781924765, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with SURF1-related conditions. ClinVar contains an entry for this variant (Variation ID: 526789). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SURF1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Inborn genetic diseases Uncertain:1
The c.808G>A (p.E270K) alteration is located in exon 8 (coding exon 8) of the SURF1 gene. This alteration results from a G to A substitution at nucleotide position 808, causing the glutamic acid (E) at amino acid position 270 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
not provided Uncertain:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at